Sort by
Refine Your Search
-
in Mass Spectrometry and Structural Glycobiology to work under the supervision of Prof. Weston Struwe for a period of 24 months. The project, funded by the UKRI, centres on developing advanced methods
-
temperature. Now, we plan to transform the material system to platform for quantum technology, a coherent 2D spin-photon interface for networks and sensing. To work towards this goal, this 2-year project will
-
with the possibility of renewal. This project addresses the high computational and energy costs of Large Language Models (LLMs) by developing more efficient training and inference methods, particularly
-
it relates to the laser process parameters. Specifically, you will carry out high resolution Raman imaging on laser written polymer networks with liquid crystal resins. Additionally, you will develop
-
molecular evolution, particularly in viruses with epidemic and pandemic potential, as well as those with significant implications for plant and animal health. This post is part of a Wellcome Trust-funded
-
, defensive mechanisms and related topics to the safe deployment of systems contain multiple LLM and VLM powered models. You will be responsible for Developing and implementing; capability evaluations, attacks
-
network telemetry. You will contribute to the development of a framework that reduces the carbon emissions of networks through the use of carbon-aware network telemetry, and the implementation of new
-
calculations and Brownian Dynamics simulations. The group is looking for a highly motivated and driven postdoctoral researcher to contribute strongly to a wave of ongoing developments deploying this technology
-
on the electrosolvation force under development in the group. The planned investigations are primarily experimental in nature, but will proceed in close conjunction with insight from theory and simulations. The ideal
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme focused on characterisation of in vivo models of myeloid neoplasms and